Thyroid autoimmunity and spontaneous cervicocranial artery dissection: an exploratory segment-specific case-control study
By
Yaqiong Yang
Zhenxiang Zhao
Ningning Che
Wei Mo
July 15, 2026
Clinical Scorecard: Exploring the Relationship Between Thyroid Autoimmunity and Spontaneous Dissection of Cervicocranial Arteries: A Segment-Specific Case-Control Analysis
At a Glance
Category Detail
Condition Spontaneous Cervicocranial Arterial Dissection (SCCAD) Key Mechanisms Immune-mediated mechanisms contributing to local vascular inflammation. Target Population Patients diagnosed with SCCAD and healthy controls. Care Setting Retrospective hospital-based case-control study.
Key Highlights
SCCAD patients showed significantly higher rates of thyroid autoimmunity positivity. Elevated TPOAb levels were positively associated with V4 segment involvement. TPOAb levels inversely associated with V3 segment involvement. Robustness of associations supported by patient-level sensitivity analyses. Guideline-Based Recommendations
Diagnosis
SCCAD diagnosed based on local symptoms and confirmed by digital subtraction angiography. Management
Monitoring & Follow-up
Risks
Exclusion criteria include severe trauma, thyroid dysfunction, and prior thyroid medication use. Patient & Prescribing Data
Euthyroid patients with SCCAD.
The study does not provide specific treatment insights.
Clinical Best Practices
Consider thyroid autoimmunity in the evaluation of SCCAD. Utilize imaging modalities to confirm SCCAD diagnosis. Related Resources & Content
